Found: 10
Select item for more details and to access through your institution.
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05444-z
- By:
- Publication type:
- Article
Lack of association between the CARD10 rs6000782 polymorphism and type 1 autoimmune hepatitis in a Japanese population.
- Published in:
- BMC Research Notes, 2015, v. 8, p. 1, doi. 10.1186/s13104-015-1733-4
- By:
- Publication type:
- Article
Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: A long-term follow-up study.
- Published in:
- Hepatology Research, 2016, v. 46, n. 3, p. E89, doi. 10.1111/hepr.12533
- By:
- Publication type:
- Article
Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0136908
- By:
- Publication type:
- Article
Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129053
- By:
- Publication type:
- Article
Association of <i>STAT4</i> Polymorphisms with Susceptibility to Type-1 Autoimmune Hepatitis in the Japanese Population.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071382
- By:
- Publication type:
- Article
Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0241002
- By:
- Publication type:
- Article
A case of cystic duct syndrome.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 3, p. 1819, doi. 10.1002/ccr3.3859
- By:
- Publication type:
- Article
Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163644
- By:
- Publication type:
- Article
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 643, doi. 10.1007/s11523-022-00921-x
- By:
- Publication type:
- Article